Published: 2019-09-25   Views: 4
Author: johndbmr
Published in: Business

Global induced pluripotent market is expected to rise to an estimated value of USD 2.33 billion by 2026, registering a substantial CAGR in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence of chronic diseases and ailments requiring the development of modern technologically advanced therapeutic options.

Induced pluripotent are a specialized form of stem cells that are extracted from either skin or blood cells, and are then modified into the pluripotent form which gives them the capability of being used for the treatment where any different kind of human cells are required. In the pluripotent form, they can be modified to any kind of cell form that is utilized for the treatment of different diseases/disorders.

Download PDF Sample report @

Competitive Analysis: Global Induced Pluripotent Market

Global induced pluripotent market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of induced pluripotent market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Induced Pluripotent Market

Few of the major competitors currently working in the induced pluripotent market are Bristol-Myers Squibb Company; CELGENE CORPORATION; Astellas Pharma Inc.; Thermo Fisher Scientific; Cell Applications, Inc.; Axol Bioscience Ltd.; Organogenesis Holdings; Merck KGaA; FUJIFILM Holdings Corporation; Fate Therapeutics; KCI Licensing, Inc.; Japan Tissue Engineering Co., Ltd.; Vericel; ViaCyte, Inc.; STEMCELL Technologies Inc.; Horizon Discovery Group plc; Lonza; Takara Bio Inc.; Promega Corporation and QIAGEN.

Market Segmentation: Global Induced Pluripotent Market

  • By Product Category (Cell Culture, Differentiation, Reprogramming, Engineering, Cell Analysis, Others)
  • By Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neurons, Others)
  • By Application (Drug Development, Regenerative Medicine, Toxicity Testing, Academic Research, Stem Cell Bio-Banking)
  • By End-User (Academic & Research Institutes, Biotechnology Companies, Hospitals)
  • By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Speak to Analyst @

Market Drivers

Rise in the expenditure incurred by various private and government sources on R&D is expected to drive the growth of the market

High levels of understanding and awareness regarding the composition of the iPSC (Induced Pluripotent Stem Cell) has resulted in a rise of demand of the product from various end-users; this factor is expected to drive the growth of the market

Utilization of these cells for the creation of customized tissues and helping in understanding of human development; this factor is expected to drive the growth of the market

Market Restraints

Complications and large costs associated with the development and manufacturing of these products are expected to restrain the growth of the market

Chances of health risks due to the acceptance of these products in the recipient’s body along with lack of efficiency in the process are factors restraining the growth of the market

Reasons to Purchase this Report

  • Current and future of global induced pluripotent market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Browse full report @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.


Data Bridge Market Research

Tel: +1-888-387-2818



Related Reports:


Global Chronic Idiopathic Constipation Treatment Market


Global Diabetic Gastroparesis Treatment Market


Author Bio

This user has not submitted a user bio yet

Disqus Comments

Articles Search


Social Media

Forum Threads Search

Pages Search